Innovation in Eye Care Heru’s advanced digital, AI-driven diagnostic solutions address a critical global demand for scalable and efficient vision care, creating opportunities for partnerships with clinics, hospitals, and eye care providers seeking modernization.

Expanding Product Portfolio The company is actively expanding its clinical programs to include additional cancer types, such as colorectal cancer, indicating a potential for cross-market expansion and collaboration with oncology treatment centers.

Financial Growth Potential With increasing revenue figures like the $11.2 million net revenue from LOQTORZI® and a recent funding of $30 million, Heru is positioned for accelerated product deployment and market penetration, appealing to investors and partners interested in innovative healthcare technology.

Leadership and Strategic Focus Heru has recently brought in new leadership, including a Chief Strategy and Corporate Affairs Officer, signaling a strategic push for business development, investor relations, and governmental partnerships, opening avenues for sales collaborations.

Global Market Opportunity With over 450 million people worldwide suffering from vision disorders and a significant shortage of trained optometry staff, Heru’s scalable diagnostic solutions present substantial sales opportunities across both healthcare and telemedicine sectors globally.